Category - New Drugs
FDA Approves Ayvakit (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor
FDA Approves Expanded Indication of Mycamine (micafungin for injection) for the Treatment of Invasive Candidiasis in Pediatric Patients Less Than 4 Months of Age
FDA Approves Keytruda (pembrolizumab) for Patients With BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer
FDA Approves Fiasp (insulin aspart injection) for the Treatment of Children with Diabetes
Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
FDA Approves Dayvigo (lemborexant) for the Treatment of Insomnia in Adult Patients
FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults
FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine